American Specialty Lab Llc

CLIA Laboratory Citation Details

2
Total Citations
44
Total Deficiencyies
19
Unique D-Tags
CMS Certification Number 29D2102809
Address 7251 W Charleston Blvd, Las Vegas, NV, 89117
City Las Vegas
State NV
Zip Code89117
Phone(702) 233-1791

Citation History (2 surveys)

Survey - October 31, 2023

Survey Type: Standard

Survey Event ID: JF7H11

Deficiency Tags: D0000 D5221 D5401 D5407 D5411 D5469 D5785 D5800 D5801 D5805 D5807 D6076 D6094 D6106 D6120 D0000 D5221 D5401 D5407 D5411 D5469 D5785 D5800 D5801 D5805 D5807 D6076 D6094 D6106 D6120

Summary:

Summary Statement of Deficiencies D0000 This Statement of Deficiencies was created as a result of an on-site CLIA recertification survey conducted at your facility on October 30-31, 2023. The findings and conclusions of any investigation by the Division of Public and Behavioral Health shall not be construed as prohibiting any criminal or civil investigations, actions or other claims for relief that may be available to any party under applicable federal, state, or local laws. D5221 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(d) All proficiency testing evaluation and verification activities must be documented. This STANDARD is not met as evidenced by: Based on a review of the 2023 internal LCMS proficiency testing laboratory records for analytes not included in an approved proficiency testing program, an interview with the laboratory supervisor, and a telephone conversation with the LCMS technologist, the laboratory failed to ensure that

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 18, 2019

Survey Type: Standard

Survey Event ID: ITMX11

Deficiency Tags: D0000 D5203 D5217 D5785 D6094 D6102 D6127 D0000 D5203 D5217 D5785 D6094 D6102 D6127

Summary:

Summary Statement of Deficiencies D0000 This Statement of Deficiencies was created as a result of an on-site CLIA recertification survey conducted at your facility on October 14 and 18, 2019. The findings and conclusions of any investigation by the Division of Public and Behavioral Health shall not be construed as prohibiting any criminal or civil investigations, actions or other claims for relief that may be available to any party under applicable federal, state, or local laws. D5203 SPECIMEN IDENTIFICATION AND INTEGRITY CFR(s): 493.1232 The laboratory must establish and follow written policies and procedures that ensure positive identification and optimum integrity of a patient's specimen from the time of collection or receipt of the specimen through completion of testing and reporting of results. This STANDARD is not met as evidenced by: Based on a random audit of patient laboratory testing requisitions and final reports from 10/24/17 through 9/05/19 and an interview with the laboratory manager, the laboratory failed to follow director approved policy to ensure positive identification of information from the time of the sample collection through the completion of testing and the reporting of the results. Findings include: 1. A random audit of patient test requisitions and patient final test reports from 10/24/17 through 9/05/19, revealed that the laboratory failed to ensure that the patient and sample information that was recorded on the patient requisition matched the information that was on the patient final test report. 2. A random patient on 5/7/18 had a recorded collection time of 12 noon on the test requisition and a collection time of 8:00 AM on the patient final test report. 3. A random patient on 10/03/18 had a recorded collection time of 12:56 PM on the test requisition and a collection time of 5:16 PM on the patient final test report. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 4 -- This was confirmed by the laboratory manager on October 18, 2019 at approximately 2:30 PM. The laboratory performs approximately 346,400 patient laboratory tests annually. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on a review of the proficiency testing reports for all non-waived tests performed by the laboratory from July 2017 through October 2019 and an interview with the laboratory manager, the laboratory failed to verify the accuracy, at least twice a year, for non-regulated non-waived laboratory tests that were not included in a Health and Human Services (HHS) approved proficiency testing program. Findings include: 1. The laboratory failed to verify the accuracy of 15 toxicology confirmation analytes, at least twice a year, for testing years 2018 and 2019. 2. The laboratory failed to verify the accuracy, at least twice a year during testing years 2018 and 2019, for the following toxicology confirmation analytes in which patient testing was performed: 2-Hydroxyethylflurazepam, 4-Hydroxyalprazolam, 4-Hydroxymidazolam, 7-Aminoflunitrazepam, Chlordiazepoxide, Desipramine, Estazolam, MDEA, Methylphenidate, Naloxone, Naltrexol, Naltrexone, Norhydrocodone and PCP. This was confirmed by the laboratory manager on October 14, 2019 at approximately 1:30 PM. The laboratory performs approximately 340,000 patient Chemistry tests annually. D5785

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access